COVAX un órgano mundial de múltiples partes interesadas que puede acarrear riesgos sanitarios y políticos para los países en desarrollo y el multilateralismo

The document critiques COVAX as a multi-stakeholder entity that marginalizes the World Health Organization (WHO) and replaces public health governance with a commercial banking model. It argues that COVAX is designed to protect the global pharmaceutical market and serve as a tool for geopolitical 'soft power' rather than ensuring equitable vaccine access. The author highlights that COVAX's funding mechanisms, dominated by a few wealthy nations and the Bill & Melinda Gates Foundation, allow private interests to influence vaccine R&D and distribution, potentially risking the health and political autonomy of developing nations.

• COVAX is characterized as operating more like a commercial bank or international financial institution than a health assistance entity, using capital to shape the global vaccine manufacturing industry and consumer markets in the Global South.
• The governance structure of COVAX effectively marginalizes the World Health Organization (WHO) by shifting decision-making power to a multi-stakeholder body where the WHO lacks a leadership role in the highest coordinating meeting.
• Funding for the COVAX Advance Market Commitment (AMC) is heavily concentrated, with governments providing 78.6% of direct donations—led by Canada, the European Commission, France, Germany, and Saudi Arabia—and the Bill & Melinda Gates Foundation providing 75.1% of foundation grants.
• The report argues that COVAX serves as a geopolitical tool for 'soft power' to confront China and Russia by controlling vaccine access for specific countries and peoples.
• There is a significant gap between the public narrative of 'equitable access' and the actual target of the COVAX AMC, which aims to vaccinate only 20% of the population in designated countries, despite WHO estimates that herd immunity requires 60-70% antibodies.
• COVAX's approach is criticized for treating health as a market commodity rather than a global public good, evidenced by its failure to support WTO intellectual property waivers that would allow developing countries to produce vaccines.

APA

Gleckman, H. (2021). COVAX un órgano mundial de múltiples partes interesadas que puede acarrear riesgos sanitarios y políticos para los países en desarrollo y el multilateralismo. Friends of the Earth International. https://www.foei.org/wp-content/uploads/2021/04/COVAX-amigos-de-la-tierra-internacional-tni.pdf

Chicago

Gleckman, Harris. COVAX un órgano mundial de múltiples partes interesadas que puede acarrear riesgos sanitarios y políticos para los países en desarrollo y el multilateralismo. Friends of the Earth International, 2021. https://www.foei.org/wp-content/uploads/2021/04/COVAX-amigos-de-la-tierra-internacional-tni.pdf.

Wikipedia

{{cite report |last1=Gleckman |first1=Harris |title=COVAX un órgano mundial de múltiples partes interesadas que puede acarrear riesgos sanitarios y políticos para los países en desarrollo y el multilateralismo |publisher=Friends of the Earth International |date=March 2021 |url=https://www.foei.org/wp-content/uploads/2021/04/COVAX-amigos-de-la-tierra-internacional-tni.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{gleckman2021covax, author = {Gleckman, Harris}, title = {{COVAX un órgano mundial de múltiples partes interesadas que puede acarrear riesgos sanitarios y políticos para los países en desarrollo y el multilateralismo}}, institution = {Friends of the Earth International}, year = {2021}, month = mar, url = {https://www.foei.org/wp-content/uploads/2021/04/COVAX-amigos-de-la-tierra-internacional-tni.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }